SYRE Competitors & Alternatives

Compare Spyre Therapeutics Inc. with similar stocks in the same industry

Biotechnology

SYRE

Main Stock
$99.97
-3.88%
Tradestie Score
37
Market Cap
$994.20M
Analyst Upside
+22.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: Monoclonal antibody engineering, Targeted biologics
Major Customers 1
N/A (pre-commercial)
Critical Suppliers 2
Contract research organizations Biomanufacturing partners
Direct Ecosystem Rivals 3

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ROIV Roivant Sciences Ltd. Common Shares
$38.77
-1.92%
$10.76B - 38 Compare
MRNA Moderna, Inc. Common Stock
$215.96
-3.32%
$10.74B - 48 Compare
BMRN BioMarin Pharmaceuticals Inc
$58.32
+1.90%
$10.53B - 54 Compare
IONS Ionis Pharmaceuticals, Inc. Common Stock
$28.57
-1.70%
$10.49B - 56 Compare
BBIO BridgeBio Pharma, Inc. Common Stock
$77.18
-1.43%
$10.22B - 42 Compare
MDGL Madrigal Pharmaceuticals, Inc. Common Stock
$423.54
-0.90%
$10.01B - 48 Compare
TECH Bio-Techne Corp.
$72.79
-0.01%
$9.33B 66.8 52 Compare
CORT Corcept Therapeutics Inc.
$69.17
-5.17%
$8.88B 55.4 50 Compare
HALO Halozyme Therapeutics, Inc.
$97.43
-2.83%
$8.77B 25.2 60 Compare
RVMD Revolution Medicines, Inc. Common Stock
$167.64
-2.70%
$8.57B - 44 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

217 stocks in this industry